Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Argenta Discovery
Argenta Discovery
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Charles River Laboratories to buy research services division of Galapagos for up to €134m
Adds in vitro drug discovery capabilities to service offering
Finance
Boehringer Ingelheim reports double-digit growth in sales for 2012
Plans launches in the oncology sector during 2013
Research & Development
Galapagos acquires Cangenix, a structure-based drug discovery company
Also sets up third drug discovery division called Fidelta
Research & Development
Galapagos acquires Argenta Discovery's service operations
Belgian biotechnology company Galapagos has bought Argenta Discovery 2009, a UK-based privately held contract research drug discovery company with 140 staff, for Euro 16.5m.
Subscribe now